Milestone pharmaceuticals stock price
WebMilestone Pharmaceuticals (MIST) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 30/03/2024 09:38:13 1-888-992-3836 Free ... WebGet Milestone Pharmaceuticals Inc (MIST:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Milestone pharmaceuticals stock price
Did you know?
Web13 apr. 2024 · Milestone Pharmaceuticals Stock Performance. NASDAQ:MIST opened at $3.67 on Wednesday. The firm’s 50-day moving average is $3.63 and its 200-day moving average is $4.57. Milestone ... WebMilestone Pharmaceuticals reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.335. Following the earnings report the stock price went down -2.256%.
WebMilestone Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Milestone Pharmaceuticals historical stock pricesstock prices Web16 jan. 2024 · January 16, 2024, 12:00 PM · 3 min read Milestone Pharmaceuticals (MIST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings...
Web31 mrt. 2024 · The latest price target for . Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on March 30, 2024.The analyst firm set a price target for $25.00 expecting MIST to rise ... WebMilestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal ...
Web5 jul. 2024 · In 2025, Milestone Pharmaceuticals stock price is expected to move from 7.98, and it will finish the year at 7.92. It is about 23.33 % from today. Furthermore, our analysis for Milestone Pharmaceuticals stock prediction says that it is expected to go down -0.80 % during 2025.
WebThe Milestone Pharmaceuticals, Inc. stock price is closed at $ 3.22 with a total market cap valuation of $ 110.40M (44M shares outstanding). The Milestone Pharmaceuticals, … linger on traductionWeb10 apr. 2024 · Milestone Pharmaceuticals Inc. (MIST) Stock Price, Quote & News - Stock Analysis Milestone Pharmaceuticals Inc. ( MIST) NASDAQ: MIST · IEX Real-Time … linger orthopedicWeb16 jan. 2024 · Milestone Pharmaceuticals Inc. (NASDAQ:MIST)’s beta value is currently sitting at 2.05, while the Average True Range indicator is currently displaying 0.30. With analysts defining $10.00-$25.00 as the low and high price targets, we arrive at a consensus price target of $16.40 for the trailing 12-month period. hot tubs sioux city iaWeb14 okt. 2024 · Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative … linge roset rucheWeb11 aug. 2024 · View the latest Milestone Pharmaceuticals Inc. (MIST) stock price, news, historical charts, analyst ratings and financial information from WSJ. MIST Milestone … hot tubs smyrna delawareWeb4 apr. 2024 · Milestone Pharmaceuticals Price Performance. Milestone Pharmaceuticals stock opened at $3.98 on Monday. Milestone Pharmaceuticals has a 12-month low of $3.10 and a 12-month high of $9.85. linger part of speechWebMedical - Biomedical and Genetics. $0.118B. $0.015B. Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2024, a nasal spray. hot tubs sioux falls south dakota